| Name | Title | Contact Details |
|---|
Intrexon Corporation (NYSE: XON) is a leader in synthetic biology focused on collaborating with companies in Health, Food, Energy, Environment, and Consumer Sectors to create biologically-based products that improve the quality of life and the health of the planet. Through the company’s proprietary UltraVector® platform and and suite of technologies, Intrexon provides its partners with industrial-scale design and development of complex biological systems. The UltraVector® platform delivers unprecedented control over the quality, function, and performance of living cells. We call our synthetic biology approach and integrated technologies Better DNA®, and we invite you to discover more at www.DNA.com.
The Brain Tumor Society is a Watertown, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MaxCare Prescription Benefit Services is a Oklahoma City, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Global Clinical Trials is a Princeton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Strategic Medical Communications is a Woodbridge, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.